| Primary information |
|---|
| ID | antitb_1761 |
| Peptide Name | FKAB-1Gw |
| Sequence | βAla-Fpa-Tic-Oic-βAla-Dpr-Tic-Oic-βAla-Fpa-Tic-Oic-βAla-Dpr-Tic-Dpr-Dpr-Dpr-Dpr- |
| N-terminal Modification | Acetylation |
| C-terminal Modification | Amidation |
| Chemical Modification | βAla = Beta alanine, Fpa = 4 Fluorophenyl alanine Tic = tetrahydroisoquinolinecarboxylic acid, Oic = Octahydroindolecarboxylic acid |
| Linear/ Cyclic | Linear |
| Length | 19 |
| Chirality | L |
| Nature | Hydrophobic |
| Source | Synthetic |
| Origin | NA |
| Species | Mycobacterium ranae |
| Strain | Mycobacterium ranae |
| Inhibition Concentartion | MIC = 100 μM |
| In vitro/In vivo | Both |
| Cell Line | None |
| Inhibition Concentartion | NA |
| Cytotoxicity | not tested |
| In vivo Model | Mice |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | None |
| Other Activities | Anti-bacterial (Salmonella typhimurium, Staphylococcus aureus, Bacillus subtillis) |
| Pubmed ID | US 2012/0197004 |
| Year of Publication | 2012 |
| 3-D Structure | NA |